Try our Advanced Search for more refined results
June 27, 2016
Track this case
Freda L. Wolfson
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.Additional or older documents may be available in Pacer.
A New Jersey federal judge on Thursday pressed the pause button on a pair of proposed shareholder class actions against Celator over its planned $1.5 billion sale to Jazz Pharmaceuticals, after the sides reached a tentative settlement agreement.
Already a subscriber? Click here to login